PHILADELPHIA - The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will sponsor the third International Cancer Immunotherapy Conference at the Rheingoldhalle Congress Center in Mainz/Frankfurt, Germany, Sept. 6-9, 2017.
The program will focus on "Translating Science into Survival," and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including neoantigens and vaccines, novel mechanisms of immunosuppression and immune evasion, biomarkers, microbiota, oncolytic viruses, new agents and their modes of action, combination therapies, adoptive cell therapies, new checkpoints, non-checkpoint immunotherapies, and the tumor microenvironment.
The full program is available here: http://www.
Registration is complimentary for credentialed news media. Members of the media can register by contacting Lauren Riley at email@example.com or 215-446-7155.
Public information officers at medical institutes and cancer centers can also register by contacting Lauren Riley.